NCT04990323 2026-03-24
US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies
ExCellThera inc.
Phase 1/2 Completed
ExCellThera inc.
IRCCS San Raffaele
Regimmune Corporation
Swedish Orphan Biovitrum
University of Liege